Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|June 26, 2026
Colorectal cancer liver metastasis: immunosuppressive microenvironment, signaling pathways, and emerging therapeutic strategiesHanlin Yang, Shaoxian Wu, Lujun ChenCurrent Treatment Options in Oncology|March 5, 2025
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and ImmunotherapyJing Jiao, You Wu, Shaoxian Wu, et al.Cytokine|October 28, 2024
Strategies for the enhancement of IL-21 mediated antitumor activity in solid tumorsYou Wu, Jing Jiao, Shaoxian Wu, et al.Journal of Immunology Research|March 11, 2026
A Comprehensive Review of AIM2 in Cancer: Functional Roles, Molecular Pathways, and Clinical RelevanceNuo Wang, Shaoxian Wu, Zhang Fang, et al.Frontiers in Immunology|January 29, 2026
CD82-associated exhausted CD8+ T cells define prognosis and immunotherapy resistance in colon cancerJingfeng Zhang, Hengwei Cui, Shaoxian Wu, et al.Current Gene Therapy|August 31, 2022
The Role of RNA m6A Modification in Cancer Glycolytic ReprogrammingYuanqi Li, Hao Huang, Shaoxian Wu, et al.Toxins|June 25, 2026
Analgesic and Neurorestorative Effects of αO-Conotoxin GeXIVA[1,2] in Diabetic Neuropathic Pain and Postherpetic NeuralgiaRongyan He, Shuting Xiao, Xiaoying Liang, et al.Cancer Cell International|September 26, 2018
Decreased RIG-I expression is associated with poor prognosis and promotes cell invasion in human gastric cancerLujun Chen, Jun Feng, Shaoxian Wu, et al.Cancer Science|October 8, 2024
CX3CR1+CD8+ T cells: Key players in antitumor immunityJiajin Ma, Yue Wu, Shaoxian Wu, et al.Journal of Translational Medicine|May 27, 2024
Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathwayMing Liu, Shaoxian Wu, Haoyu Wu, et al.Pageof 4